Interventions for structural heart disease

Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry

EuroIntervention 2014;10:842-849. DOI: 10.4244/EIJV10I7A144

Nicolas Amabile
Nicolas Amabile1*, MD, PhD; Helene Agostini2, MD, PhD; Martine Gilard3, MD, PhD; Helene Eltchaninoff4, MD, PhD; Bernard Iung5, MD; Patrick Donzeau-Gouge6, MD, PhD; Karine Chevreul7, MD; Jean Fajadet8, MD; Pascal Leprince9, MD; Alain Leguerrier10, MD; Michel Lievre11, PhD; Alain Prat12, MD; Emmanuel Teiger13, MD, PhD; Marc Laskar14, MD; Chri
1. Institut Mutualiste Montsouris, Paris, France; 2. CHU Bicêtre-AP-HP, Le Kremlin-Bicêtre, France; 3. CHU Brest, Hôpital de la Cavale Blanche, Brest, France; 4. CHU Rouen, Rouen, France; 5. CHU Bichat-AP-HP, Paris, France; 6. Institut Jacques Cartier, Ma

Aims: To assess the relationship between a low preprocedural (<40 mmHg) mean transaortic gradient (MTG) and cardiovascular mortality f

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic stenosisoutcomestranscatheter aortic valve implantation
Read next article
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Latest news